[P2] Poster Session Core Time (偶数番号)

[P2-26] Confidential

*Genta FURUYA¹, Taiga KIMISHIMA¹, Satoru NAGATOISHI², Rae MAEDA³, Keishu TAKAHASHI¹, Ryutaro TAMANO¹, Tomoya OHNO¹, Tomoki YOSHIHARA⁴, Kengo SASAKI¹, Naoki MORITA¹, Gao PENG¹, Fabian EISENSTEIN⁷, Hirofumi KOSUGE², Masumi SHIRAKAWA⁶, Hiroyuki ARAI⁸, Radostin DANEV⁷, Masahide KIKKAWA⁷, Shinsuke SANDO⁶, Naoshi DOHMAE⁵, Toshio HAKOSHIMA⁴, Yuki SUGIURA³, Kohei TSUMOTO², Reiko SHINKURA¹ (1. Laboratory of Immunology and Infection Control, Institute for Quantitative Biosciences, The University of Tokyo (Japan), 2. Department of Bioengineering, School of Engineering, The University of Tokyo (Japan), 3. Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine (Japan), 4. Division of Biological Science, Graduate School of Science and Technology, Nara Institute of Science and Technology (Japan), 5. Biomolecular Characterization Unit, RIKEN Center for Sustainable Resource Science (Japan), 6. Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo (Japan), 7. Department of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyo (Japan), 8. Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo (Japan))